Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Sysmex ( (JP:6869) ) has provided an announcement.
Sysmex Corporation reported that its actual financial results for the six months ending September 30, 2025, were below the forecasted figures due to weaker sales in China and Japan. Consequently, the company has revised its full-year financial forecast for the fiscal year ending March 31, 2026, anticipating declines in net sales, operating profit, and profit attributable to owners. The company is adjusting its foreign exchange assumptions and aims to improve profitability by controlling expenses, although challenges in key markets persist.
The most recent analyst rating on (JP:6869) stock is a Hold with a Yen2000.00 price target. To see the full list of analyst forecasts on Sysmex stock, see the JP:6869 Stock Forecast page.
More about Sysmex
Sysmex Corporation operates in the healthcare industry, specializing in the development and production of diagnostic systems and reagents. The company focuses on providing innovative solutions for clinical testing and laboratory diagnostics, catering to a global market with a significant presence in regions such as China and Japan.
Average Trading Volume: 2,955,511
Technical Sentiment Signal: Sell
Current Market Cap: Yen1077B
For an in-depth examination of 6869 stock, go to TipRanks’ Overview page.